Sotio

Sotio

Signal active

Investment Firm

Overview

Sotio is an international biotechnology company leading the efforts of PPF Group to build a diverse biotechnology portfolio through its own research & development, collaborations, in-licensing, investments, mergers, and acquisitions. The company is developing new medical therapies, focusing on the treatment of cancer and autoimmune diseases. The most advanced project is the SOTIO proprietary platform of active cellular immunotherapy (ACI) based on dendritic cells.

Highlights

Founded

2010

Industry

Biotechnology

Employees

101-250

Investment

1

Lead Investment

0

Exits

undefined

Stages

Early Stage Venture

Investor Type

N/A

Location

Europe

Contact Information

Social

Profile Resume

Sotio, established in 2010 and headquartered in Europe., specializes in Early Stage Venture investments across Biotechnology, Health Care, Therapeutics, Oncology, Finance. Their recent investments include MaveriX Oncology, PPF Group. The highest investment round they participated in was $156.0M. Among their most notable exits are MaveriX Oncology and PPF Group. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Radek Spisek

Radek Spisek

Chief Executive Officer and Founder

imagePlace Robyn Hunter

Robyn Hunter

Chief Financial Officer

Investment portfolio

Sotio has made 1 investments. Their most recent investment was on Oct 14, 2019, when MaveriX Oncology raised $6.5M.

investments

1

Diversity investments

0

Lead investments

0

Number of exits

undefined

Investments

1

Annouced DateOrganization NameIndustryMoney Raised
Oct 14, 2019
MaveriX Oncology MaveriX Oncology
Biotechnology6.5M

Exits

0

Funding Timeline

Funding rounds

1

Investors

1

Funds

0

Funding Rounds

1

Sotio has raised 1 rounds. Their latest funding was raised on Oct 14, 2019 from a Series A - MaveriX Oncology round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Oct 14, 2019
Series A - MaveriX Oncology Series A - MaveriX Oncology
-6.5M-

Investors

2

Sotio is funded by 2 investor(s). PPF Group Kantor is the most recent investors.

Investor NameLead InvestorFunding RoundMoney Raised
-No
Venture Round - Sotio
300.0K
PPF Group PPF Group
Yes
Venture Round - Sotio
316.6M

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.